FINWIRES · TerminalLIVE
FINWIRES

Intuit's Low-Cost Customer Push May Pressure Growth, BofA Says

By

Intuit (INTU) is planning to improve its underlying trends by focusing on customer acquisition actions through more free and low-cost offerings, which may pressure near-term growth and profitability, BofA Securities said Wednesday.

Intuit's weak fiscal 2027 guidance reflects trends that appear misaligned with investor expectations. Rather than higher-value Assisted offerings driving growth, TurboTax is losing share to lower-cost AI-based alternatives, according to the note.

Fiscal Q4 had several bright spots, as Assisted Tax, Money, and Mid-Market grew 34% collectively, accounting for 30% of revenue. The brokerage believes Intuit's value lies in its proprietary data, domain expertise, and human-assisted offerings, the note added.

Management expects TurboTax growth of just 2.2%, compared with Street estimates of 6.8%, reflecting share loss to lower-cost AI alternatives and the impact of 2026 new customer weakness on 2027 upgrades, the brokerage said.

Management also lowered its long-term growth target for Global Business Solutions to 10% to 15% from 15% to 20%, the brokerage added.

BofA downgraded Intuit to Neutral from Buy and lowered its price target to $360 from $400.

Price: $344.20, Change: $-13.26, Percent Change: -3.71%

Related Articles

Wire

Update: Worley Fiscal 2026 Underlying EPS, Aggregated Revenue Down; Shares Hit Six-Year Low

(Updates to add stock movement in the headline and the last paragraph.)Worley (ASX:WOR) logged AU$0.782 in underlying earnings per basic share for fiscal 2026, compared with AU$0.902 a year ago, a Wednesday filing showed.Analysts polled by FactSet expected AU$0.77.For the 12 months ended June 30, aggregated revenue was AU$12.02 billion versus AU$12.05 billion previously, the Australia-listed provider of engineering and project delivery services added. Analysts surveyed by FactSet projected AU$11.73 billion.The board proposed a final dividend of AU$0.25 per share, unchanged from a year earlier, payable Sept. 30 to shareholders of record as of Sept. 2.The company guided for fiscal 2027 underlying earnings before interest, taxes, and amortization growth, and for aggregated revenue growth, in the mid-to-high single-digit range.Its shares fell nearly 11% in recent trading on Wednesday and earlier hit their lowest since August 2020.

ASX:WOR
Wire

Update: HEICO Fiscal Q3 Earnings, Revenue Rise

(Updates to add share movement in the fifth paragraph.)HEICO (HEI) reported late Tuesday a fiscal Q3 earnings of $1.67 per diluted share, up from $1.26 a year earlier.Analysts polled by FactSet expected $1.51.Revenue for the quarter ended July 31 was $1.41 billion, up from $1.15 billion a year ago.Analysts expected $1.35 billion.Shares of the company rose 2.5% in after-hours trading.

$HEI
Wire

Spyre Halts Stand-Alone Rheumatoid Arthritis Drug Development; Shares Fall After Hours

Spyre Therapeutics (SYRE) said its experimental rheumatoid arthritis drug SPY072 failed to meet the company's internal performance threshold needed to justify further stand-alone development, prompting the halt of its monotherapy RA program.The drug delivered statistically significant improvements over placebo on several efficacy measures and showed a tolerable safety profile with no drug-related serious adverse events, the company said Tuesday in a statement.Spyre said it will now evaluate SPY072 in combination regimens and in other autoimmune indications, with additional clinical readouts expected in Q4.Spyre shares fell 12% in after-hours trading.

$SYRE